SCHEMBL5566520

SCHEMBL5566520

CCCN(C)c1cc(N(NC(=O)CC(=O)c2cccc(-c3cc(C)nc(C)c3)c2)C(=O)OC(C)(C)C)ccc1C(F)(F)F

nearest known ligand 0.35

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
RXRA P19793 1/20 0.32
CRHR1 P34998 2/20 0.31
SYK P43405 1/20 0.30
ERN1 O75460 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7115204 0.81 KMO (0.36)
SCHEMBL5563298 0.80 POLB (0.35)
SCHEMBL7109630 0.77 CSF1R (0.38)
SCHEMBL6636112 0.76 PGR (0.32)
SCHEMBL7113378 0.76 ABL1 (0.38)
SCHEMBL17336825 0.75 RXFP1 (0.35)
SCHEMBL7112784 0.75 SCN5A (0.35) SYK
SCHEMBL7047983 0.75 AAK1 (0.33) SYK
SCHEMBL17336851 0.74 POLB (0.35) RXRA
SCHEMBL7117074 0.74 ABL1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1474416-B1 DIHYDROBENZODIAZEPIN-2-ONE-DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS HOFFMANN LA ROCHE (CH) 2007-09-26 EP disclosed